Physician profile
Robert Butler
NPI 1942228549
$1,381.86
in general payments reported to CMS, 2019-2025
17 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $146 · 2023: $369 · 2024: $617 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $181.71 | 2023-2025 | |
| Glaxosmithkline, LLC. | $180.05 | 2022-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $161.60 | 2023-2024 | Ozempic, Rybelsus |
| Anika Therapeutics, INC. | $141.42 | 2024 | Integrity |
| Astellas Pharma US INC | $139.27 | 2024 | Veozah |
| Lilly USA, LLC | $124.02 | 2025 | Mounjaro |
| Abbvie INC. | $117.32 | 2023-2024 | Qulipta, Mavyret |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $81.50 | 2022-2023 | |
| Abbott Laboratories | $48.28 | 2024 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $44.58 | 2023 | Delstrigo, Pifeltro, Gardasil 9 |
| Amgen INC. | $36.12 | 2022-2024 | Otezla, Repatha |
| Teva Pharmaceuticals USA, INC. | $23.94 | 2023 | Austedo |
| Pfizer INC. | $23.23 | 2024 | |
| Exact Sciences Corporation | $22.78 | 2024 | Cologuard Collection Kit |
| Viiv Healthcare Company | $22.36 | 2023 | Rukobia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.35 | 2023 | Aptima, Thinprep 2000 Processor |
| Cranial Technologies, INC | $15.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.